Cetera Investment Advisers Madrigal Pharmaceuticals, Inc. Transaction History
Cetera Investment Advisers
- $42.2 Billion
- Q2 2024
A detailed history of Cetera Investment Advisers transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 1,540 shares of MDGL stock, worth $546,469. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,540
Previous 2,253
31.65%
Holding current value
$546,469
Previous $601,000
28.29%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MDGL
# of Institutions
292Shares Held
21.8MCall Options Held
756KPut Options Held
370K-
Janus Henderson Group PLC London, X02.49MShares$882 Million0.38% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.06MShares$729 Million7.86% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$701 Million7.35% of portfolio
-
Rtw Investments, LP New York, NY1.92MShares$680 Million8.96% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny1.85MShares$656 Million39.74% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $6.07B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...